Publication | Closed Access

Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways

HepatologyMedicineLiver PhysiologyPathologyCell DeathCancer BiologyHepatotoxicityLiver CancerAstragaloside IvOncologyCell BiologyCancer ResearchHepatocellular CarcinomaTumor BiologyNrf2/ho-1 Pathways